Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity (2019 - 2025)

Historic Return on Equity for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.28%.

  • Eton Pharmaceuticals' Return on Equity rose 900.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.19% for FY2024, which is 1300.0% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Return on Equity of 0.28% as of Q3 2025, which was up 900.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Equity ranged from a high of 0.13% in Q3 2023 and a low of 0.9% during Q2 2022
  • Over the past 5 years, Eton Pharmaceuticals' median Return on Equity value was 0.37% (recorded in 2024), while the average stood at 0.38%.
  • In the last 5 years, Eton Pharmaceuticals' Return on Equity skyrocketed by 48700bps in 2021 and then crashed by -6300bps in 2022.
  • Eton Pharmaceuticals' Return on Equity (Quarter) stood at 0.12% in 2021, then plummeted by -533bps to 0.74% in 2022, then soared by 92bps to 0.06% in 2023, then plummeted by -227bps to 0.19% in 2024, then crashed by -50bps to 0.28% in 2025.
  • Its Return on Equity was 0.28% in Q3 2025, compared to 0.17% in Q2 2025 and 0.19% in Q1 2025.